LBF20207PG28: Difference between revisions
m (LBF20307PG12 moved to LBF20207PG28) |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=LMFA03010148 | |LipidMaps=LMFA03010148 | ||
|SysName=9-oxo-11alpha,15S-dihydroxy-prosta-5E,13E-dien-1-oic acid | |SysName=9-oxo-11alpha,15S-dihydroxy-prosta-5E,13E-dien-1-oic acid | ||
|Common Name=&&5-trans Prostaglandin | |Common Name=&&5-trans Prostaglandin E_2&& | ||
}} | }} |
Revision as of 07:30, 19 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1711 |
LipidMaps | LMFA03010148 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG28 |
5-trans Prostaglandin E2 | |
---|---|
Structural Information | |
9-oxo-11α,15S-dihydroxy-prosta-5E,13E-dien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|